Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Paclitaxel-induced Peripheral Neuropathy”

81 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 81 results

Not applicableUnknownNCT04446819
What this trial is testing

Compression Gloves to Reduce Albumin-binding Paclitaxel Induced Peripheral Sensory and Motor Neurotoxicity (REMAINING)

Who this might be right for
Peripheral Neuropathy
Fudan University 70
Not applicableStudy completedNCT03272919
What this trial is testing

Chemotherapy Induced Peripheral Neuropathy (CIPN)

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Loma Linda University 44
Not applicableStudy completedNCT05374876
What this trial is testing

Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy

Who this might be right for
Adenocarcinoma of Pancreas
HonorHealth Research Institute 49
Testing effectiveness (Phase 2)WithdrawnNCT04675450
What this trial is testing

NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

Who this might be right for
Breast CancerPeripheral Neuropathy
Conjupro Biotherapeutics, Inc.
Not applicableStudy completedNCT03299582
What this trial is testing

PREventing CHemotherapy Induced Neuropathy (PreChIN)

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy (CIPN)
National University Hospital, Singapore 89
Testing effectiveness (Phase 2)UnknownNCT04582591
What this trial is testing

Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Zealand University Hospital 54
Not applicableLooking for participantsNCT07427537
What this trial is testing

Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients

Who this might be right for
Cancer, LungColon NeoplasmNeuropathy;Peripheral
University Hospital, Clermont-Ferrand 90
Not applicableWithdrawnNCT06052345
What this trial is testing

Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes

Who this might be right for
Breast NeoplasmsBreast CancerEarly-stage Breast Cancer+5 more
Theodoros Foukakis
Testing effectiveness (Phase 2)Study completedNCT05322889
What this trial is testing

Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel)

Who this might be right for
Neuropathic PainChemotherapy Effect
Dr. Frank Behrens 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05751668
What this trial is testing

Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Chemotherapy-Induced Peripheral NeuropathyMetastatic Breast Carcinoma
Alliance for Clinical Trials in Oncology 7
Testing effectiveness (Phase 2)Study completedNCT06135493
What this trial is testing

Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients

Who this might be right for
Peripheral Neuropathy Due to Chemotherapy
Future University in Egypt 84
Not applicableLooking for participantsNCT02610439
What this trial is testing

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

Who this might be right for
Breast CarcinomaNeuropathy
National Cancer Institute (NCI) 575
Large-scale testing (Phase 3)Not Yet RecruitingNCT04715542
What this trial is testing

Stibium Metallicum Praeparatum D6 Versus Placebo in the Reduction of Paclitaxel-induced Peripheral Neurotoxicity

Who this might be right for
Chemotherapy Induced Peripheral Neuropathy (CIPN)
University of Bern 86
Testing effectiveness (Phase 2)Study completedNCT06538272
What this trial is testing

Study to Investigate the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Onset-Suppressing Effect and Safety of ONO-2910 in Patients With Breast Cancer Receiving Weekly Paclitaxel

Who this might be right for
CIPN - Chemotherapy-Induced Peripheral Neuropathy
Ono Pharmaceutical Co., Ltd. 210
Large-scale testing (Phase 3)Looking for participantsNCT06994507
What this trial is testing

GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy (CIPN)
Qilu Pharmaceutical Co., Ltd. 352
Testing effectiveness (Phase 2)Study completedNCT06459193
What this trial is testing

Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy

Who this might be right for
Peripheral Neuropathy Due to Chemotherapy
Minia University 60
Not applicableLooking for participantsNCT05341141
What this trial is testing

Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy

Who this might be right for
Breast Cancer
Peking University 102
Not applicableLooking for participantsNCT06400849
What this trial is testing

Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy

Who this might be right for
Non-metastatic Breast Cancer
Centre Antoine Lacassagne 60
Not applicableLooking for participantsNCT04415892
What this trial is testing

The Role of TRP Channels in CIPN

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Universitaire Ziekenhuizen KU Leuven 240
Not applicableNot Yet RecruitingNCT06422949
What this trial is testing

Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy

Who this might be right for
Breast CancerNeuropathy;Peripheral
European Institute of Oncology 120
Next Page